MG217 Multi-Symptom Treatment Cream
Wisconsin Pharmacal is recalling MG217 Multi-Symptom Treatment Cream due to Staphylococcus aureus contamination.
Immediately stop using the recalled treatment cream and discard the product.
Why it was recalled
Wisconsin Pharmacal is recalling MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%) due to microbial contamination. The product has been found to contain Staphylococcus aureus, which poses a risk of infection.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
- Recall #
- D-0553-2026
Where it was sold
Distributed nationwide.
Official source
Editorial summary by Recall Canary · last updated 2026-05-30 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification